HIGH POINT, N.C.--(BUSINESS WIRE)--Dec. 21, 2005--TransTech Pharma, Inc. today announced a worldwide research and license collaboration with Boehringer Ingelheim GmbH using TransTech’s proprietary TTP Translational Technology(R). The aim of the collaboration is to discover and develop novel small molecules as therapeutics against an undisclosed biological target of interest to both companies.
